Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SPDEF contributors: mct/npt/pgu - updated : 01-12-2015
HGNC name SAM pointed domain containing ets transcription factor
HGNC id 17257
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two putative PEST sequences : one near the N terminus and the other at the center of the protein
  • a central pointed domain, which is characteristic of some ETS family members
  • an ETS DNA-binding domain
  • mono polymer complex
    HOMOLOGY
    interspecies ortholog to murine Spdef (88.3pc)
    Homologene
    FAMILY
  • ETS (epithelial-specific E26 transforming sequence) family
  • CATEGORY transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • androgen independent transcriptional activator of the PSA promoter
  • regulator of prostate gland or prostate cancer development
  • acting as a transcriptional activator for SERPINB5 promoter
  • critical regulator of genes involved in cell motility, invasion, and adhesion of prostate cancer cells
  • in multiple invasive breast cancer cells, its expression inhibits cell migration by preventing the acquisition of directional morphological polarity conferred by changes in cytoskeleton organization
  • regulates goblet cell hyperplasia in the airway epithelium
  • important role in regulating intestinal epithelial cell homeostasis and differentiation, and regulates terminal differentiation and maturation of intestinal goblet cells
  • is potentially a negative regulator of tumor progression by modulating the expression of growth and migration promoting genes
  • required for mucous gland cell function in the gastric antrum
  • plays a critical role in regulating a transcriptional network mediating IL13-induced MUC5AC synthesis dependent on STAT6
  • negative regulator of tumor progression and metastasis
  • plays a significant role in tumorigenesis in prostate, breast, colon, and ovarian cancer, and functions as a tumor metastasis suppressor
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS development
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA binding to 5'-GGAT- 3' DNA sequences
    RNA
    small molecule
    protein
  • the DNA-binding domain of the androgen receptor
  • NKX3-1
  • STMN1 is downregulated by PDEF, suggesting that PDEF may inhibit prostate cancer progression by transcriptional downregulation of oncogenic STMN expression
  • involved in G2/M transition and degradation of several transcription factors, CDK11A directly interacts with and phosphorylates SPDEF on serine residues, leading to subsequent ubiquitination and degradation of SPDEF through the proteasome pathway
  • GADD45A and GADD45G, directly interact with CDK11A and thereby inhibit CDK11A activity, and consequentially SPDEF phosphorylation and degradation, ultimately reducing prostate cancer cell migration and invasion
  • cell & other
    REGULATION
    induced by by interleukin (IL13)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in prostate cancer and in metastatic breast cancer in axillary lymph node
    tumoral     --low  
    leads to a morphologic change, increased migration and invasiveness in prostate cancer cells, reminiscent of transforming growth factor beta (TGFbeta) function and epithelial-to-mesenchymal transition
    tumoral     --over  
    prostate tumor cells where it regulates prostate-specific antigen gene expression and is an androgen receptor co-regulator
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • up-regulation is associated with a favorable prognosis in patients with clinically localized prostate cancer
  • Therapy target
    SystemTypeDisorderPubmed
    neurosensorialear 
    ATOH1 and SPDEF could be the therapeutic targets for otitis media associated with mucous cell metaplasia which is frequently considered "intractable" in the clinical settings
    ANIMAL & CELL MODELS